Research Topics
| Luca RicheldiSummaryAffiliation: University of Modena and Reggio Emilia Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Performance of tests for latent tuberculosis in different groups of immunocompromised patientsLuca Richeldi
Section of Respiratory Diseases, Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Italy
Chest 136:198-204. 2009....
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosisPaola Contini
Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena, Italy
Multidiscip Respir Med 6:313-7. 2011....- Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosisLuca Richeldi
Centre for Rare Lung Disease, Policlinico University Hospital, Modena, Italy
Eur Respir Rev 21:147-51. 2012..The findings of this systematic review, although not presenting new original data, together with an acceptable safety profile, suggest that pirfenidone may have a role in IPF treatment... - Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosisLuca Richeldi
Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo 71, 41100 Modena, Italy
Thorax 67:407-11. 2012..It is unknown if the method of calculating decline in FVC (relative vs. absolute change) impacts its frequency or its ability to predict mortality... - Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosisLuca Richeldi
Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
N Engl J Med 365:1079-87. 2011.... 
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assayLuca Richeldi
Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo 71, 41100 Modena, Italy
Expert Rev Respir Med 2:253-60. 2008....- [Role of in vitro tests in the diagnosis of latent tubercular infections]Luca Richeldi
Dipartimento di Oncologia, Ematologia e Patologie dell Apparato Respiratorio, Universita di Modena e Reggio Emilia, Italy
G Ital Med Lav Ergon 32:269-72. 2010..It's therefore desirable that new documents will be produced soon to guide the use of these new tests in clinical routine... - Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescentsBarbara Maria Bergamini
University of Modena and Reggio Emilia, Department of Respiratory Diseases, Policlinico Hospital of Modena, Via del Pozzo 71, 41100 Modena, Italy
Pediatrics 123:e419-24. 2009..TB (Oxford Immunotec, Abingdon, United Kingdom) show promise of greater accuracy, but they may also be affected by impaired cellular immunity, resulting in indeterminate results (ie, insufficient response in positive-control wells)... - Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective studyGiovanni Ferrara
Section of Respiratory Disease, Department of Oncology, Haematology, and Respiratory Disease, University of Modena and Reggio Emilia, Via del Pozzo, 71-41100 Modena, Italy
Lancet 367:1328-34. 2006..Rates of indeterminate and positive results, however, differ between the blood tests, suggesting that they might provide different results in routine clinical practice... - T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infectionLuca Richeldi
Department of Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy
Pediatrics 119:e1-5. 2007..Our findings demonstrate that this blood test detected latent infection with dormant, yet viable, bacilli and illustrate how enzyme-linked immunospot could improve diagnosis of childhood tuberculosis infection... - Sarcoidosis: challenging diagnostic aspects of an old diseasePaolo Spagnolo
Section of Respiratory Diseases, Department of Oncology, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy
Am J Med 125:118-25. 2012..In conclusion, we strongly advise that physicians be ready to reconsider the diagnosis of sarcoidosis in the presence of atypical manifestations or persistent/progressive disease despite conventional therapy... - Management of idiopathic pulmonary fibrosisStefania Cerri
Center for Rare Lung Diseases, Department of Oncology, Hematology and Respiratory Diseases, University Hospital Policlinico of Modena, Modena, Italy
Clin Chest Med 33:85-94. 2012..Randomized controlled trials represent a valid choice for patients with IPF, and their completion is important in improving both survival and quality of life... - Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infectionGiovanni Ferrara
Section of Respiratory Disease, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy
Am J Respir Crit Care Med 172:631-5. 2005..As with the TST, immunosuppression may negatively affect the test's performance, with a significant rate of indeterminate results in the most vulnerable population... - Early diagnosis of subclinical multidrug-resistant tuberculosisLuca Richeldi
University of Modena and Reggio Emilia and Azienda Ospedaliera Policlinico di Modena, Modena, Italy
Ann Intern Med 140:709-13. 2004..Large prospective studies that compare benefits and costs of this alternative to tuberculin skin testing are needed... - The big clinical trials in idiopathic pulmonary fibrosisFabrizio Luppi
Center for Rare Lung Diseases, University Hospital of Modena, Modena, Italy
Curr Opin Pulm Med 18:428-32. 2012..Some of the most relevant trials have been published only recently... - An update on the diagnosis of tuberculosis infectionLuca Richeldi
Department of Oncology, Hematology, and Respiratory Disease, University of Modena and Reggio Emilia, 41100 Modena, Italy
Am J Respir Crit Care Med 174:736-42. 2006.... - Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literatureMichele Colaci
Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy
Autoimmun Rev 12:374-9. 2013..Our study confirmed the higher frequency of lung cancer among SSc patients compared to general population, particularly within patients' subset with serum anti-Scl70 antibodies and lung involvement... - Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY programLuca Richeldi
University of Modena and Reggio Emilia, Modena, Italy
Expert Rev Respir Med 5:473-81. 2011..It is likely that pirfenidone will be utilised in many countries as first-line therapy and will also be included in studies of combination therapy for this attritional disease... - Genetic testing in diffuse parenchymal lung diseasePaolo Spagnolo
Department of Oncology, Center for Rare Lung Disease, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena, 41124, Italy
Orphanet J Rare Dis 7:79. 2012..Finally, we discuss practical issues and implications for both patients and physicians of recent advances in the genetics of sarcoidosis and IPF... - Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patientAlberto Franchi
Occupational Health Unit, Policlinico Hospital, 8th Floor, room 8 056, Via Largo del Pozzo 71, 41100 Modena, Italy
Int Arch Occup Environ Health 80:533-8. 2007..e., index case (IC)]. Aim of the study was to identify the main exposure predictors for the risk of conversion through evaluation of tuberculin screening results... - Environmental triggers and susceptibility factors in idiopathic granulomatous diseasesPaolo Spagnolo
Research Center on Rare Lung Diseases MaRP, Department of Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy
Semin Respir Crit Care Med 29:610-9. 2008..Unraveling how genetic risk factors and environmental triggers interact to determine the disease is challenging but will inevitably have an impact on both diagnostic and therapeutic strategies in granulomatous lung diseases... - Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?Fabrizio Luppi
Clinic of Respiratory Disease, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy
Sarcoidosis Vasc Diffuse Lung Dis 22:S74-84. 2005..The aim of this review is to describe the level of evidence available on the efficacy of corticosteroids and immunosuppressive, antifibrotic, or immunomodulatory therapies in the treatment of different IIPs... - A culture-proven case of community-acquired legionella pneumonia apparently classified as nosocomial: diagnostic and public health implicationsAnnalisa Bargellini
Department of Clinical, Diagnostic and Public Health Medicine, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy
Case Rep Med 2013:303712. 2013.... - Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challengesPaolo Spagnolo
Center for Rare Lung Disease, University Hospital of Modena, Via del Pozzo 71, 41124, Modena, Italy
Multidiscip Respir Med 7:42. 2012..However, a multidisciplinary approach to this complex disease is steadily improving diagnostic accuracy, while recent advances in the pharmacological therapy offer the genuine promise of future treatments for this devastating disease... - MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patientsMilena Nasi
Department of Biomedical Sciences, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41100 Modena, Italy
AIDS 17:1696-8. 2003..The MDR1 C3435Tpolymorphism did not influence response to therapy, suggesting no disadvantages for individuals with a different genotype...